BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 20215435)

  • 41. Rnr1's role in telomere elongation cannot be replaced by Rnr3: a role beyond dNTPs?
    Maicher A; Kupiec M
    Curr Genet; 2018 Jun; 64(3):547-550. PubMed ID: 29119271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of dNTP pool imbalances on frameshift fidelity during DNA replication.
    Bebenek K; Roberts JD; Kunkel TA
    J Biol Chem; 1992 Feb; 267(6):3589-96. PubMed ID: 1371272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Function and regulation of yeast ribonucleotide reductase: cell cycle, genotoxic stress, and iron bioavailability.
    Sanvisens N; de Llanos R; Puig S
    Biomed J; 2013; 36(2):51-8. PubMed ID: 23644233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in deoxynucleoside triphosphate pools induced by inhibitors and modulators of ribonucleotide reductase.
    Fox RM
    Pharmacol Ther; 1985; 30(1):31-42. PubMed ID: 3915820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DNA precursor asymmetries, replication fidelity, and variable genome evolution.
    Mathews CK; Ji J
    Bioessays; 1992 May; 14(5):295-301. PubMed ID: 1637360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of biological DNA precursor pool asymmetry upon accuracy of DNA replication in vitro.
    Martomo SA; Mathews CK
    Mutat Res; 2002 Feb; 499(2):197-211. PubMed ID: 11827713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ribonucleotide reductase and deoxyribonucleotide pools.
    Reichard P
    Basic Life Sci; 1985; 31():33-45. PubMed ID: 3888178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitation of cellular deoxynucleoside triphosphates.
    Ferraro P; Franzolin E; Pontarin G; Reichard P; Bianchi V
    Nucleic Acids Res; 2010 Apr; 38(6):e85. PubMed ID: 20008099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acetylation regulates ribonucleotide reductase activity and cancer cell growth.
    Chen G; Luo Y; Warncke K; Sun Y; Yu DS; Fu H; Behera M; Ramalingam SS; Doetsch PW; Duong DM; Lammers M; Curran WJ; Deng X
    Nat Commun; 2019 Jul; 10(1):3213. PubMed ID: 31324785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deoxyribonucleoside triphosphate pools in human diploid fibroblasts and their modulation by hydroxyurea and deoxynucleosides.
    Snyder RD
    Biochem Pharmacol; 1984 May; 33(9):1515-8. PubMed ID: 6732868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. dNTP pool levels modulate mutator phenotypes of error-prone DNA polymerase ε variants.
    Williams LN; Marjavaara L; Knowels GM; Schultz EM; Fox EJ; Chabes A; Herr AJ
    Proc Natl Acad Sci U S A; 2015 May; 112(19):E2457-66. PubMed ID: 25827226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enzyme regulation. IRBIT is a novel regulator of ribonucleotide reductase in higher eukaryotes.
    Arnaoutov A; Dasso M
    Science; 2014 Sep; 345(6203):1512-5. PubMed ID: 25237103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA damage and cell cycle regulation of ribonucleotide reductase.
    Elledge SJ; Zhou Z; Allen JB; Navas TA
    Bioessays; 1993 May; 15(5):333-9. PubMed ID: 8343143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nucleoside Analogue Triphosphates Allosterically Regulate Human Ribonucleotide Reductase and Identify Chemical Determinants That Drive Substrate Specificity.
    Knappenberger AJ; Ahmad MF; Viswanathan R; Dealwis CG; Harris ME
    Biochemistry; 2016 Oct; 55(41):5884-5896. PubMed ID: 27634056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Activation of deoxyribonucleotide synthesis by radioprotectants and antioxidants as a key stage in formation of body resistance to DNA-damaging factors].
    Sharygin VL; Pulatova MK; Shliakova TG; Mitrokhin IuI; Todorov IN
    Izv Akad Nauk Ser Biol; 2005; (4):401-22. PubMed ID: 16212261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Substrate Specificity of SAMHD1 Triphosphohydrolase Activity Is Controlled by Deoxyribonucleoside Triphosphates and Phosphorylation at Thr592.
    Jang S; Zhou X; Ahn J
    Biochemistry; 2016 Oct; 55(39):5635-5646. PubMed ID: 27588835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deoxyribonucleotide metabolism and cyclic AMP resistance in hydroxyurea-resistant S49 T-lymphoma cells.
    Albert DA; Gudas LJ; Nodzenski E
    J Cell Physiol; 1987 Feb; 130(2):262-9. PubMed ID: 3029148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bromodeoxyuridine mutagenesis, ribonucleotide reductase activity, and deoxyribonucleotide pools in hydroxyurea-resistant mutants.
    Ashman CR; Reddy GP; Davidson RL
    Somatic Cell Genet; 1981 Nov; 7(6):751-68. PubMed ID: 7034251
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of perturbations of pools of deoxyribonucleoside triphosphates on expression of ribonucleotide reductase, a G1/S transition state enzyme, in p53-mutated cells.
    Wadler S; Horowitz R; Zhang HY; Schwartz EL
    Biochem Pharmacol; 1998 May; 55(9):1353-60. PubMed ID: 10076525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imbalanced deoxyribonucleoside triphosphate pools and spontaneous mutation rates determined during dCMP deaminase-defective bacteriophage T4 infections.
    Sargent RG; Mathews CK
    J Biol Chem; 1987 Apr; 262(12):5546-53. PubMed ID: 3553179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.